125 related articles for article (PubMed ID: 17373566)
1. Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients.
Ang-Lee K; Oreskovich MR; Saxon AJ; Jaffe C; Meredith C; Ellis ML; Malte CA; Knox PC
J Psychoactive Drugs; 2006 Dec; 38(4):505-12. PubMed ID: 17373566
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine dosing regime in the management of out-patient heroin withdrawal.
Lintzeris N
Drug Alcohol Rev; 2002 Mar; 21(1):39-45. PubMed ID: 12189003
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC
Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843
[TBL] [Abstract][Full Text] [Related]
4. Rapid heroin detoxification using a single high dose of buprenorphine.
Kutz I; Reznik V
J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
[TBL] [Abstract][Full Text] [Related]
5. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
Blennow G; Fergusson A; Medvedeo A
Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
[TBL] [Abstract][Full Text] [Related]
7. Heroin detoxification with buprenorphine on an inpatient psychiatric unit.
DiPaula BA; Schwartz R; Montoya ID; Barrett D; Tang C
J Subst Abuse Treat; 2002 Oct; 23(3):163-9. PubMed ID: 12392802
[TBL] [Abstract][Full Text] [Related]
8. Rapid detoxification of heroin dependence by buprenorphine.
Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of one-day vs. three-day buprenorphine inpatient detoxification protocols for heroin dependence.
Hopper JA; Wu J; Martus W; Pierre JD
J Opioid Manag; 2005; 1(1):31-5. PubMed ID: 17315409
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.
Amass L; Pukeleviciene V; Subata E; Almeida AR; Pieri MC; D'Egidio P; Stankova Z; Costa A; Smyth BP; Sakoman S; Wei Y; Strang J
Addiction; 2012 Jan; 107(1):142-51. PubMed ID: 21749526
[TBL] [Abstract][Full Text] [Related]
11. Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine.
Ponizovsky AM; Grinshpoon A; Margolis A; Cohen R; Rosca P
Addict Behav; 2006 Nov; 31(11):2002-13. PubMed ID: 16524668
[TBL] [Abstract][Full Text] [Related]
12. Development of buprenorphine for the treatment of opioid dependence.
Johnson RE; Fudala PJ
NIDA Res Monogr; 1992; 121():120-41. PubMed ID: 1383825
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts.
Jain K; Jain R; Dhawan A
J Opioid Manag; 2011; 7(1):11-20. PubMed ID: 21434580
[TBL] [Abstract][Full Text] [Related]
14. Effects of a high-dose fast tapering buprenorphine detoxification program on symptom relief and treatment retention.
Palmstierna T
J Psychoactive Drugs; 2004 Jun; 36(2):273-7. PubMed ID: 15369209
[TBL] [Abstract][Full Text] [Related]
15. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.
White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL
Drug Alcohol Depend; 2009 Jul; 103(1-2):37-43. PubMed ID: 19403243
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine suppresses heroin use by heroin addicts.
Mello NK; Mendelson JH
Science; 1980 Feb; 207(4431):657-9. PubMed ID: 7352279
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
Lanier RK; Umbricht A; Harrison JA; Nuwayser ES; Bigelow GE
Addiction; 2007 Oct; 102(10):1648-56. PubMed ID: 17854341
[TBL] [Abstract][Full Text] [Related]
18. A comparative clinical study of the effect of WeiniCom, a Chinese herbal compound, on alleviation of withdrawal symptoms and craving for heroin in detoxification treatment.
Hao W; Zhao M
J Psychoactive Drugs; 2000; 32(3):277-84. PubMed ID: 11061678
[TBL] [Abstract][Full Text] [Related]
19. Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose.
Clark NC; Lintzeris N; Muhleisen PJ
Med J Aust; 2002 Feb; 176(4):166-7. PubMed ID: 11913917
[TBL] [Abstract][Full Text] [Related]
20. The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients.
Welsh CJ; Suman M; Cohen A; Broyles L; Bennett M; Weintraub E
Am J Addict; 2002; 11(2):135-40. PubMed ID: 12028743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
